AMAM

Ambrx Biopharma Inc

Delisted

AMAM was delisted on the 6th of March, 2024.

44 hedge funds and large institutions have $568M invested in Ambrx Biopharma Inc in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17.6M
Puts
$4.66M
Net Calls
Net Calls Change

Top Sellers

1 -$37.3M
2 -$11.6M
3 -$5.76M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.17M
5
Holocene Advisors
Holocene Advisors
New York
-$4.91M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$580K
27
$577K
28
$545K
29
$544K
30
$524K
31
$391K
32
$365K
33
$358K
34
$283K
35
$255K
36
$78.1K
37
$75K
38
$64.1K
39
$32K
40
$24.8K
41
$15.9K
42
$11.7K
43
$5.75K
44
$2.7K
45
46
47
48
49
50